EGF and diabetic kidney disease: The results strongly indicate that in T1DM, serum EGF concentration might serve as a useful marker to detect microangiopathy, while GDF-15 may probably be engaged to some extent in microvascular damage as a marker of diabetic kidney disease, peripheral neuropathy, and retinopathy.